Genetic Crop Design Company Evogene Sets Up Agricultural Biology Subsidiary
LaVie Bio will focus on the fields of food quality and agricultural sustainability and productivity, through the introduction of microbiome-based biological products
17:4727.02.19
Nasdaq and Tel Aviv-listed genetic crops design company Evogene Ltd. announced Tuesday the establishment of new agricultural biology subsidiary LaVie Bio Ltd. In a statement, Evogene said that LaVie will focus on the fields of food quality and agricultural sustainability and productivity, through the introduction of microbiome-based ag-biological products.
For daily updates, subscribe to our newsletter by clicking here.
Evogene uses computational predictive biology to develop novel crop strains and pesticides, in a variety of related domains, including agricultural chemicals, agricultural biological, and human microbiome-based therapeutics.
Evogene launched its ag-biologicals division in 2015. Ido Dor, previously general manager of Evogene’s ag-biologicals division, was appointed CEO of LaVie. Ofer Haviv, Evogene's CEO, will serve as chairman of the board of directors of the new subsidiary.
Corn. Photo: Shutterstockצילום: שאטרסטוק
